Schön Klinik Berchtesgadener Land
schoen-klinik.deTotal trials
51
Active
4
Phase 3
0
Total enrollment
3,084
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Chronic Obstructive Pulmonary Disease21
- COPD10
- Idiopathic Pulmonary Fibrosis3
- Pulmonary Rehabilitation3
- Lung Diseases, Interstitial2
- POST-Covid 192
- Hypercapnia2
- Post-COVID191
Frequently asked questions about Schön Klinik Berchtesgadener Land
- How many clinical trials does Schön Klinik Berchtesgadener Land have on ClinicalTrials.gov?
- Schön Klinik Berchtesgadener Land is listed as the lead sponsor on 51 clinical trials in ClinicalTrials.gov, 4 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Schön Klinik Berchtesgadener Land's trials are in Phase 3?
- 0 of Schön Klinik Berchtesgadener Land's trials are in Phase 3.
- What therapeutic areas does Schön Klinik Berchtesgadener Land focus on?
- Schön Klinik Berchtesgadener Land's most-studied conditions on ClinicalTrials.gov are Chronic Obstructive Pulmonary Disease, COPD, Idiopathic Pulmonary Fibrosis, Pulmonary Rehabilitation, Lung Diseases, Interstitial.